Analogs of Cyclic Peptide Mortiamide‐D From Marine Fungi Have Improved Membrane Permeability and Kill Drug‐Resistant Melanoma Cells
Open Access
- 17 August 2024
- journal article
- research article
- Published by Wiley in Peptide Science
- Vol. 117 (1)
Abstract
Targeted melanoma therapies, including treatment with the small molecule drug dabrafenib, can become ineffective due to acquired drug resistance. Dabrafenib targets BRAF‐V600E, a mutation that is present in more than half of melanoma cancers. Therefore, drug discovery efforts need to explore alternative candidate molecules that selectively target and kill melanoma cells via mechanisms different to those of current drugs. Marine fungi are an underexplored resource for bioactive molecules. Mortiamide‐D, a seven amino acid cyclic peptide from Mortierella sp, is an example molecule with desirable features for drug development. We synthesized mortiamide‐D and three rationally designed analogs and observed modest micromolar activity against HT144 melanoma cells that are sensitive or resistant to dabrafenib. By contrast, mortiamide‐D and analogs did not kill noncancer HaCaT cells at these concentrations. Substitution of D‐Ile at position 7 with D‐Arg improved membrane permeability and enhanced potency against HT144 cells via a mode‐of‐action that includes perturbation of mitochondrial membrane potential. These studies suggest the potential of mortiamides as modifiable scaffolds for developing a new class of molecule for targeting melanoma cells.Keywords
Funding Information
- Australian Research Council (CE200100012)
- National Health and Medical Research Council (1183927, 2009564)
- Natural Sciences and Engineering Research Council of Canada
This publication has 51 references indexed in Scilit:
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040JAMA Dermatology, 2022
- Antimicrobial peptides provide wider coverage for targeting drug‐resistant bacterial pathogensPeptide Science, 2021
- Cyclic gomesin, a stable redesigned spider peptide able to enter cancer cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2021
- Physiological roles of transverse lipid asymmetry of animal membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2020
- Lipid composition of the cancer cell membraneJournal of Bioenergetics and Biomembranes, 2020
- Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agentsBioorganic & Medicinal Chemistry, 2018
- Cyclotides as drug design scaffoldsCurrent Opinion in Chemical Biology, 2017
- Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible BicyclizationAngewandte Chemie International Edition, 2016
- Cyclization of the Antimicrobial Peptide Gomesin with Native Chemical Ligation: Influences on Stability and BioactivityChemBioChem, 2013
- Peptide–membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006